Francesca Barone
Chief Scientific Officer · 2 filings · Latest: Jun 29, 2026
Candel Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CADL | Francesca Barone | Chief Scientific Officer | Jun 29, 2026 | Sale | $10.06 | 23,447 | $235.8K | 77,362 | |
CADL | FRANCESCA BARONE | — | Jun 29, 2026 | Proposed Sale | $9.79 | 23,447 | $229.5K | — | |
CADL | FRANCESCA BARONE | — | Mar 18, 2025 | Proposed Sale | $8.83 | 32,146 | $283.8K | — | |
CADL | Barone Francesca | — | Jan 15, 2025 | Proposed Sale | $7.84 | 12,452 | $97.6K | — | |
CADL | Barone Francesca | — | Jan 8, 2025 | Proposed Sale | $8.35 | 13,440 | $112.2K | — | |
CADL | Barone Francesca | — | Nov 29, 2024 | Proposed Sale | $4.95 | 20,085 | $99.4K | — |